Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-16-010524
Filing Date
2016-06-06
Accepted
2016-06-06 18:02:30
Documents
1
Period of Report
2016-06-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT formfour.html 4  
1 OWNERSHIP DOCUMENT formfour.xml 4 3271
  Complete submission text file 0001171843-16-010524.txt   4696
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

EIN.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DENDREON CORPORATION 1301 2ND AVENUE SEATTLE WA 98101
Business Address
JOHNSON JOHN (Reporting) CIK: 0001410781 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33609 | Film No.: 161699542